Pain, Mood, and Substance Abuse in HIV
Implications for Clinic Visit Utilization, Antiretroviral Therapy Adherence, and Virologic Failure
In the article by Merlin et al, appearing in JAIDS: Journal of Acquired Immune Deficiency Syndromes, Vol. 61, No. 2, pp. 164-170 entitled “Pain, Mood, and Substance Abuse in HIV: Implications for Clinic Visit Utilization, Antiretroviral Therapy Adherence, and Virologic Failure”, there were errors in the substance abuse variable. Forty-two individuals were misclassified into the current substance abuse category. Thirty-seven of these individuals are now classified as not having substance abuse and the remaining 5 have missing data. The authors have repeated all of their analyses, and the updated tables are shown below. In addition to these tables, the P value reported in the text for the interaction between pain and substance abuse in Table 2 is now 0.0029 (was 0.0022). These changes do not affect the statistical significance of any of the reported odds ratios, and do not change the conclusions of the article.
© 2013 Lippincott Williams & Wilkins, Inc.
Merlin JS, Westfall AO, Raper JL, et al.. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61:164–170.